Zebinix eslicarbazepine acetate regulatory update

Eisai Co. Ltd. (Tokyo:4523, Tokyo, Japan) said Finnish Health Authorities granted full reimbursement for Zebinix eslicarbazepine acetate for adjunctive therapy in adults with partial onset seizures, with or without secondary generalization. Eisai has marketing rights to the product from Bial-Portela in Europe, where it is approved for the indication. ...